Followers | 28 |
Posts | 2446 |
Boards Moderated | 0 |
Alias Born | 11/22/2010 |
![](https://investorshub.advfn.com/uicon/227822.png?cb=1513916256)
Wednesday, October 21, 2015 8:23:49 AM
I'm hoping that it's a JV with someone who has a production facility or a deal that's in the works that will require them to deliver on product.
It just seems obvious to me something is going on. ASPIRE (if you look at their company profile) don't just jump in feet first. They analyze the business to see what the needs are and if related to essential business growth to get a near enough sure thing to market and/or the need to deliver on existing contracts.... well those are the investments they go after.
Fingers crossed they went into MBLX and it was a no-brainer to buy the over 5M Shares shares that they did at current market Value = 2.79 on the day.
*For Certain Aspire appear to be a conservative, risk adverse Investment fund. I get confidence out of this as well as the terms of the agreement.
All my posts on this board obviously come with a big Caveat Emptor. Just my opinions! and not to be construed as investment advice
As we know anything is possible when investing in a company at this stage of their development and growth..
Recent YTEN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 07:15:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:11:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:10:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:09:48 AM
- Yield10 Bioscience Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/14/2024 08:37:26 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/29/2024 08:01:34 PM
- Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets • GlobeNewswire Inc. • 07/17/2024 10:45:00 PM
- Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets • GlobeNewswire Inc. • 07/17/2024 12:30:39 PM
- Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina • GlobeNewswire Inc. • 06/17/2024 12:32:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:31:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:09:03 PM
- Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label • GlobeNewswire Inc. • 05/23/2024 12:32:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:03:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:01:57 PM
- Yield10 Bioscience Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/15/2024 08:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:48:23 PM
- Yield10 Bioscience Announces Delisting from Nasdaq • GlobeNewswire Inc. • 05/15/2024 12:30:21 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 05/09/2024 03:15:37 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/07/2024 08:01:17 PM
- Yield10 Bioscience Announces 1-for-24 Reverse Stock Split • GlobeNewswire Inc. • 05/01/2024 12:30:00 PM
- Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/01/2024 08:01:07 PM
- Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024 • GlobeNewswire Inc. • 03/28/2024 08:01:20 PM
- Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada • GlobeNewswire Inc. • 03/26/2024 12:29:24 PM
- USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States • GlobeNewswire Inc. • 03/21/2024 12:29:14 PM
- Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests • GlobeNewswire Inc. • 02/29/2024 01:31:04 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM